Your browser doesn't support javascript.
loading
Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL.
Blumenberg, Viktoria; Busch, Galina; Baumann, Stephan; Jitschin, Regina; Iacoboni, Gloria; Gallur, Laura; Iraola-Truchuelo, Josu; Hoster, Eva; Winkelmann, Michael; Hellwig, Konstantin; Schmidt, Christian; Frölich, Lisa; Tast, Benjamin; Hildebrand, Friederike; Rejeski, Kai; Dekorsy, Franziska; Schmidkonz, Christian; Bäuerle, Tobias; Kunz, Wolfgang G; Mougiakakos, Dimitrios; Müller, Fabian; von Bergwelt-Baildon, Michael; Barba, Pere; Bücklein, Veit L; Mackensen, Andreas; Völkl, Simon; Subklewe, Marion.
Afiliação
  • Blumenberg V; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Busch G; Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.
  • Baumann S; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
  • Jitschin R; Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Iacoboni G; Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.
  • Gallur L; Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.
  • Iraola-Truchuelo J; Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
  • Hoster E; Department for Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany.
  • Winkelmann M; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Hellwig K; Department of Medicine, Universitat Autònoma of Barcelona, Barcelona, Spain.
  • Schmidt C; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Frölich L; Department of Medicine, Universitat Autònoma of Barcelona, Barcelona, Spain.
  • Tast B; Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Hildebrand F; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Rejeski K; Institute for Medical Informatics, Biometry and Epidemiology, LMU Munich, Munich, Germany.
  • Dekorsy F; Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Schmidkonz C; Department of Radiology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany.
  • Bäuerle T; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Kunz WG; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Mougiakakos D; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
  • Müller F; Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.
  • von Bergwelt-Baildon M; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Barba P; Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
  • Bücklein VL; Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany.
  • Mackensen A; German Cancer Consortium (DKTK), partner site Munich, Munich, Germany.
  • Völkl S; Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany.
  • Subklewe M; Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Blood Adv ; 7(22): 6844-6849, 2023 11 28.
Article em En | MEDLINE | ID: mdl-37748131

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos de Linfócitos T / Linfócitos T Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article